| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3a2139e032013a5a8b0bc4bdde3a10bf |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-165
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2469-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-375
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56983
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-375
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14 |
| filingDate |
2021-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bf9b86095a829dc031a08becadd6fb79
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_be962711357bc3b619de8a9be1136839
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0d9e45bdcfbc1e69fcce17ab51f11c58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3840cfe573b586a94c7650f35bf236de
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_40c9f0a4a8921f0ef27047018c73fb9b |
| publicationDate |
2021-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-113527449-A |
| titleOfInvention |
Targeting recognition peptide aiming at novel coronavirus SARS-CoV-2 spinous process protein and application |
| abstract |
The invention discloses a target recognition peptide aiming at new coronavirus SARS-CoV-2 spinous process protein, belonging to the technical field of biological engineering, wherein the target recognition peptide is specifically combined with the new coronavirus SARS-CoV-2 spinous process glycoprotein to block the combination of the SARS-CoV-2 spinous process glycoprotein and angiotensin converting enzyme 2 receptor, thereby achieving the effect of blocking virus infection and propagation; the target recognition peptide and the mutant structure thereof can be specifically combined with the spinous process glycoprotein (S protein) of the new coronavirus SARS-CoV-2 to block the infection and spread of the new coronavirus; the preparation has high titer and strong specificity, can be efficiently expressed, is used for qualitative or quantitative detection of the new coronavirus, can neutralize and weaken certain toxicity of the new coronavirus, and achieves the purpose of preventing or/and treating the new coronavirus pneumonia. |
| priorityDate |
2021-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |